Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a cash flow conversion efficiency ratio of -0.075x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₫-135.66 Billion ≈ $-5.15 Million USD) by net assets (₫1.82 Trillion ≈ $69.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Binh Dinh Pharmaceutical and Medical Equ liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Binh Dinh Pharmaceutical and Medical Equipment JSC - Cash Flow Conversion Efficiency Trend (2020–2025)
This chart illustrates how Binh Dinh Pharmaceutical and Medical Equipment JSC's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Binh Dinh Pharmaceutical and Medical Equipment JSC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Binh Dinh Pharmaceutical and Medical Equipment JSC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hanyang Sec
KO:001750
|
-0.120x |
|
Taskus Inc
NASDAQ:TASK
|
0.168x |
|
Nordic Aqua Partners As
OL:NOAP
|
-0.140x |
|
Kginicis Co.Ltd
KQ:035600
|
0.020x |
|
Dynamix Corporation
NASDAQ:ETHM
|
-0.001x |
|
Dynamix Corp
NASDAQ:DYNC
|
-0.001x |
|
NorAm Drilling AS
F:TM9
|
0.094x |
|
Wah Hong Industrial
TWO:8240
|
0.029x |
Annual Cash Flow Conversion Efficiency for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
The table below shows the annual cash flow conversion efficiency of Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025. For the full company profile with market capitalisation and key ratios, see Binh Dinh Pharmaceutical and Medical Equ market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₫1.72 Trillion ≈ $65.40 Million |
₫615.19 Billion ≈ $23.37 Million |
0.357x | +124.27% |
| 2024-12-31 | ₫1.66 Trillion ≈ $63.11 Million |
₫264.73 Billion ≈ $10.06 Million |
0.159x | -22.33% |
| 2023-12-31 | ₫1.43 Trillion ≈ $54.44 Million |
₫293.99 Billion ≈ $11.17 Million |
0.205x | +68.50% |
| 2022-12-31 | ₫1.36 Trillion ≈ $51.49 Million |
₫165.01 Billion ≈ $6.27 Million |
0.122x | +18.13% |
| 2021-12-31 | ₫1.14 Trillion ≈ $43.33 Million |
₫117.57 Billion ≈ $4.47 Million |
0.103x | -52.14% |
| 2020-12-31 | ₫988.63 Billion ≈ $37.56 Million |
₫212.91 Billion ≈ $8.09 Million |
0.215x | -- |
About Binh Dinh Pharmaceutical and Medical Equipment JSC
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous … Read more